Historie von Umsatz, Gewinn und Cashflow aus den offiziellen Geschäftsberichten.
The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International.
Interaktive Charts und vollständige Abschlüsse ansehen → Bewertungsmodell (DCF) →
| Gewinn- und Verlustrechnung | TTM → 2026-06-30 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 | 2011-06-30 | 2010-06-30 | 2009-06-30 | 2008-06-30 | 2007-06-30 | 2006-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gesamtumsatz | $6.7B | $6.7B | $7.1B | $7.1B | $7.4B | $7.1B | $7.3B | $6.7B | $6.2B | $6.1B | $6.0B | $5.8B | $5.7B | $5.5B | $5.5B | $5.5B | $5.2B | $5.2B | $5.5B | $5.3B | $4.8B | $4.6B |
| Bruttoergebnis | $2.8B | $2.8B | $3.2B | $3.0B | $2.9B | $2.5B | $3.2B | $3.1B | $2.7B | $2.7B | $2.7B | $2.6B | $2.5B | $2.4B | $2.4B | $2.3B | $2.3B | $2.3B | $2.3B | $2.2B | $2.1B | $2.0B |
| Bruttomarge % | 42.3% | 42.3% | 45.2% | 43.0% | 39.4% | 35.8% | 43.6% | 45.6% | 43.9% | 43.7% | 44.7% | 45.1% | 43.6% | 42.7% | 43.2% | 42.1% | 43.5% | 44.3% | 43.0% | 41.2% | 43.1% | 42.2% |
| Betriebsergebnis (EBIT) | $886M | $886M | $1.2B | $723M | $823M | $719M | $1.2B | $1.3B | $1.1B | $1.1B | $1.1B | $1.1B | $1.0B | $969M | $964M | $903M | $921M | $973M | $1.0B | $888M | $867M | $779M |
| Operative Marge % | 13.2% | 13.2% | 16.6% | 10.2% | 11.1% | 10.1% | 16.7% | 18.8% | 17.8% | 18.4% | 18.7% | 18.3% | 17.7% | 17.6% | 17.4% | 16.5% | 17.6% | 18.6% | 18.7% | 16.8% | 17.9% | 16.8% |
| Jahresüberschuss | $587M | $587M | $810M | $280M | $149M | $462M | $710M | $939M | $820M | $823M | $701M | $648M | $580M | $558M | $572M | $541M | $557M | $603M | $537M | $461M | $501M | $444M |
| Nettomarge % | 8.7% | 8.7% | 11.4% | 4.0% | 2.0% | 6.5% | 9.7% | 14.0% | 13.2% | 13.4% | 11.7% | 11.2% | 10.3% | 10.1% | 10.3% | 9.9% | 10.7% | 11.5% | 9.8% | 8.7% | 10.3% | 9.6% |
| EBITDA | — | — | $1.4B | $723M | $564M | $937M | $1.2B | $1.5B | $1.3B | $1.3B | $1.3B | $1.2B | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B | $1.2B | $1.1B | $1.1B | $967M |
| Ergebnis je Aktie (EPS) | — | $4.81 | $6.52 | $2.24 | $1.20 | $3.73 | $5.58 | $7.35 | $6.32 | $6.25 | $5.33 | $4.92 | $4.37 | $4.24 | $4.30 | $4.08 | $4.03 | $4.26 | $3.81 | $3.25 | $3.25 | $2.90 |
| Ausstehende Aktien (Mio.) | — | — | 124M | 125M | 124M | 124M | 127M | 128M | 130M | 132M | 132M | 132M | 133M | 132M | 133M | 133M | 138M | 142M | 141M | 142M | 154M | 153M |
Quelle: veröffentlichte Unternehmensberichte (SEC). Bitte prüfen Sie die Zahlen vor Verwendung auf SEC EDGAR.
Bilanzen, Cashflow-Rechnungen, Quartalsdaten und alle Kennzahlen finden Sie im interaktiven Viewer für CLX. /companies/us/CLX
Die Informationen auf dieser Website dienen ausschließlich Bildungs- und Informationszwecken und stellen keine Anlageberatung dar. Es werden keine Kursziele und keine Anlageurteile veröffentlicht.
About TickerBase · Data methodology & sources · Privacy · Terms